middle.news
InhaleRx Secures $38.5M to Accelerate Inhaled Drug Trials for Cancer Pain and Panic Disorder
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
InhaleRx Secures $38.5M to Accelerate Inhaled Drug Trials for Cancer Pain and Panic Disorder
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Secured $38.5 million funding agreement with Clendon Biotech Capital
Completed Phase 1 trial report for IRX-211 targeting breakthrough cancer pain
Filed international patent application under PCT for IRX-211
Appointed Ingenu CRO for upcoming Phase 1 and Phase 2 clinical trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IRX
OPEN ARTICLE